A day before a pan-India dry run of Covid vaccination by Center, the subject expert committee of the national drugs regulator Central Drugs Standard Control Organisation (CDSCO) will meet again on Friday to take a decision on the emergency-use authorization (EUA) application of Serum Institute of India’s Oxford-AstraZeneca and Bharat Biotech’s Covid vaccine candidates.from IndiaTV India: Google News Feed https://ift.tt/3mZ6qOo
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.